Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment

Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment

Glioblastoma (GBM), characterized by fast growth and invasion into adjacent tissue, is the most aggressive cancer of brain origin. Current protocols, which include cytotoxic chemotherapeutic agents, effectively treat localized disease; however, these aggressive therapies present side effects due to...

Full description

Bibliographic Details
Main Authors: Salomé Araujo-Abad, Antonio Manresa-Manresa, Enrique Rodríguez-Cañas, María Fuentes-Baile, Pilar García-Morales, Ricardo Mallavia, Miguel Saceda, Camino de Juan Romero
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
glioblastoma
small EVs
nanocarriers
temozolomide
EPZ015666
FESEM
Online Access:https://www.mdpi.com/1422-0067/24/6/5910

Similar Items

Similar Items